|
|
|
Volumn 141, Issue 31, 2000, Pages 1711-1714
|
|
Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer;Lanzoprazol- vagy ranitidin bizmut citrát-tartalmú hármas kezelés a Helicobacter pylori-fertózés eradikációjában nyombélfekélyes betegekben.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
BISMUTH;
CLARITHROMYCIN;
DRUG DERIVATIVE;
LANSOPRAZOLE;
METRONIDAZOLE;
OMEPRAZOLE;
RANITIDINE;
RANITIDINE BISMUTH CITRATE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
DUODENUM ULCER;
FEMALE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
BISMUTH;
CLARITHROMYCIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
DUODENAL ULCER;
FEMALE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
METRONIDAZOLE;
MIDDLE AGED;
OMEPRAZOLE;
PROSPECTIVE STUDIES;
RANITIDINE;
TREATMENT OUTCOME;
|
|
EID: 0034734051
PISSN: 00306002
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
